Inhalytix®+ from Copley is an innovative software package that revolutionises cascade impaction workflows by connecting equipment, automating data transfer and centralising analysis in a single validated system.

As the global leader in inhaler testing solutions, Copley has deep expertise in the needs of orally inhaled and nasal drug product (OINDP) analysts working in busy labs to deliver data of exemplary quality, as efficiently as possible. Automated, flexible and fully compliant, Inhalytix+ has the potential to significantly enhance lab productivity and data integrity.

"Inhalytix+ is all about efficiently accelerating the analytical process from measurement through to reliable metrics for decision-making," said Jamie Clayton, CEO of Copley Scientific. "It’s a centralised, connected platform that pulls together all the data needed for cascade impaction analysis and transforms it into fully traceable aerodynamic particle size distribution (APSD) metrics with just a few clicks. It is simple, powerful and built for the way labs work today."

Cascade impaction remains a core analytical technique for all orally inhaled products (OIPs) and is routinely used for nasal drug products too. It produces significant quantities of data which must be mathematically processed to generate APSD metrics. These are critical quality attributes for OIPs. Inhalytix+ optimises and accelerates every stage of this process. It’s a solution centred on connectivity that consolidates operation reports and other critical data, supports better inventory tracking, reduces manual entry, and ensures all information is securely centralised, eliminating the inefficiencies of fragmented systems.

The all-new Inhalytix+:

• Manages every step of APSD measurement, integrating method setup, equipment metadata and result analysis.
• Connects directly with key inhaler testing equipment including flow controllers, breathing simulators and automation solutions such as shake and fire devices, cup coaters and drug recovery tools.
• Includes a unique Equipment Bench feature that enables users to save and reuse their own specific equipment configurations while tracking usage for full traceability.
• Has compliance built in. It supports 21 CFR Part 11 and is GMP-ready with complete audit trails and controlled data sign off.

"If you’re looking to eliminate manual data handling, spreadsheet-based workflows, and disconnected processes, Inhalytix+ is the solution," said Clayton. "It offers a structured, compliant approach to cascade impaction data analysis. And with a subscription-based model, it stays current with evolving regulatory guidance and software updates, keeping your lab ahead of the curve. It’s a solution with the power to transform analytical practice."

Trust Inhalytix+ from Copley to take care of your cascade impaction data analysis.

Recent news from Copley